137 related articles for article (PubMed ID: 33173250)
1. Towards a novel peptide vaccine for Middle East respiratory syndrome coronavirus and its possible use against pandemic COVID-19.
Khan S; Shaker B; Ahmad S; Abbasi SW; Arshad M; Haleem A; Ismail S; Zaib A; Sajjad W
J Mol Liq; 2021 Feb; 324():114706. PubMed ID: 33173250
[TBL] [Abstract][Full Text] [Related]
2. Designing spike protein (S-Protein) based multi-epitope peptide vaccine against SARS COVID-19 by immunoinformatics.
Singh H; Jakhar R; Sehrawat N
Heliyon; 2020 Nov; 6(11):e05528. PubMed ID: 33225084
[TBL] [Abstract][Full Text] [Related]
3. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2.
Behmard E; Soleymani B; Najafi A; Barzegari E
Sci Rep; 2020 Nov; 10(1):20864. PubMed ID: 33257716
[TBL] [Abstract][Full Text] [Related]
4. Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches.
Waqas M; Haider A; Sufyan M; Siraj S; Sehgal SA
Front Mol Biosci; 2020; 7():227. PubMed ID: 33195402
[TBL] [Abstract][Full Text] [Related]
5. Epitope-Based Potential Vaccine Candidate for Humoral and Cell-Mediated Immunity to Combat Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic.
Das BK; Chakraborty D
J Phys Chem Lett; 2020 Nov; 11(22):9920-9930. PubMed ID: 33174418
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice.
Pollet J; Chen WH; Versteeg L; Keegan B; Zhan B; Wei J; Liu Z; Lee J; Kundu R; Adhikari R; Poveda C; Villar MJ; de Araujo Leao AC; Rivera JA; Momin Z; Gillespie PM; Kimata JT; Strych U; Hotez PJ; Bottazzi ME
bioRxiv; 2021 Feb; ():. PubMed ID: 33173864
[TBL] [Abstract][Full Text] [Related]
7. Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approach.
Sarkar B; Ullah MA; Araf Y; Rahman MS
Inform Med Unlocked; 2020; 21():100478. PubMed ID: 33200088
[TBL] [Abstract][Full Text] [Related]
8. A computational study to disclose potential drugs and vaccine ensemble for COVID-19 conundrum.
Ahmad S; Waheed Y; Ismail S; Abbasi SW; Najmi MH
J Mol Liq; 2021 Feb; 324():114734. PubMed ID: 33199930
[TBL] [Abstract][Full Text] [Related]
9. Designing of Nucleocapsid Protein Based Novel Multi-epitope Vaccine Against SARS-COV-2 Using Immunoinformatics Approach.
Kumar J; Qureshi R; Sagurthi SR; Qureshi IA
Int J Pept Res Ther; 2021; 27(2):941-956. PubMed ID: 33192207
[TBL] [Abstract][Full Text] [Related]
10. Safety, Tolerability, and Immunogenicity of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
Yuan P; Ai P; Liu Y; Ai Z; Wang Y; Cao W; Xia X; Zheng JC
medRxiv; 2020 Nov; ():. PubMed ID: 33173896
[TBL] [Abstract][Full Text] [Related]
11. The Race for a COVID-19 Vaccine: Current Trials, Novel Technologies, and Future Directions.
Brown S; Brown T; Cederna PS; Rohrich RJ
Plast Reconstr Surg Glob Open; 2020 Oct; 8(10):e3206. PubMed ID: 33173705
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory Syndrome.
Dolzhikova IV; Grousova DM; Zubkova OV; Tukhvatulin AI; Kovyrshina AV; Lubenets NL; Ozharovskaia TA; Popova O; Esmagambetov IB; Shcheblyakov DV; Evgrafova IM; Nedorubov AA; Gordeichuk IV; Gulyaev SA; Botikov AG; Panina LV; Mishin DV; Loginova SY; Borisevich SV; Deryabin PG; Naroditsky BS; Logunov DY; Gintsburg AL
Acta Naturae; 2020; 12(3):114-123. PubMed ID: 33173601
[TBL] [Abstract][Full Text] [Related]
13. Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19.
Kuo TY; Lin MY; Coffman RL; Campbell JD; Traquina P; Lin YJ; Liu LT; Cheng J; Wu YC; Wu CC; Tang WH; Huang CG; Tsao KC; Chen C
Sci Rep; 2020 Nov; 10(1):20085. PubMed ID: 33208827
[TBL] [Abstract][Full Text] [Related]
14. A multiple peptides vaccine against COVID-19 designed from the nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the immunoinformatics approach.
Abd Albagi SO; Al-Nour MY; Elhag M; Tageldein Idris Abdelihalim A; Musa Haroun E; Adam Essa ME; Abubaker M; Deka H; Ghosh A; Hassan MA
Inform Med Unlocked; 2020; 21():100476. PubMed ID: 33200089
[TBL] [Abstract][Full Text] [Related]
15. Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach.
Rahman MS; Hoque MN; Islam MR; Akter S; Rubayet Ul Alam ASM; Siddique MA; Saha O; Rahaman MM; Sultana M; Crandall KA; Hossain MA
PeerJ; 2020; 8():e9572. PubMed ID: 33194329
[TBL] [Abstract][Full Text] [Related]
16. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
Oliveira SC; de Magalhães MTQ; Homan EJ
Front Immunol; 2020; 11():587615. PubMed ID: 33193414
[TBL] [Abstract][Full Text] [Related]
17. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
Reche PA
Front Immunol; 2020; 11():586984. PubMed ID: 33178220
[TBL] [Abstract][Full Text] [Related]
18. Innate immunity plays a key role in controlling viral load in COVID-19: mechanistic insights from a whole-body infection dynamics model.
Dogra P; Ruiz-Ramírez J; Sinha K; Butner JD; Peláez MJ; Rawat M; Yellepeddi VK; Pasqualini R; Arap W; Sostman HD; Cristini V; Wang Z
medRxiv; 2020 Nov; ():. PubMed ID: 33173913
[TBL] [Abstract][Full Text] [Related]
19. The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition.
Hattori T; Koide A; Panchenko T; Romero LA; Teng KW; Tada T; Landau NR; Koide S
bioRxiv; 2020 Nov; ():. PubMed ID: 33173869
[TBL] [Abstract][Full Text] [Related]
20. Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach.
Ayyagari VS; T C V; K AP; Srirama K
J Biomol Struct Dyn; 2022 Apr; 40(7):2963-2977. PubMed ID: 33252008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
